Cuprina Holdings (Cayman) LTD (CUPR) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
CUPR currently has 7.37M outstanding shares. with significant dilution risk as 3.75M authorized shares could dilute existing holders by 50.9%. The company has significantly diluted shareholders by 88.12% over the past 2 years, indicating aggressive capital raising.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Apr 27, 2026 |
20-F filing | 7.4M shares outstanding |
7.4M | 3.8M |
| May 14, 2025 |
20-F filing | 7.4M shares outstanding |
7.4M | 3.8M |
| Dec 17, 2024 |
RW filing: The company is withdrawing the registration statement because it no longer plans to consummate the offering described in the registration statement. |
3.9M | 3.8M |
| Dec 06, 2024 |
RW filing: The company is withdrawing the registration statement because it no longer plans to consummate the offering described in the registration statement and represents that no securities were sold in connection with the registration statement. |
N/A | 3.8M |
| Dec 06, 2024 |
F-1 filing: This F-1 filing outlines an initial public offering of Class A Ordinary Shares for a Singapore-based biomedical and biotechnology company focused on chronic wound care and cosmeceutical products. |
3.9M | 3.8M |
| Mar 07, 2024 |
F-1 filing: This is an F-1 filing for Class A Ordinary Shares. The company intends to use the net proceeds from this offering primarily for research and development activities, growth and expansion into new markets as well as investment in equipment and infrastructure. |
N/A | 0 |